Behavioral and Emotional Challenges in Children With Spinal Muscular Atrophy

Lakshmi Balaji1, Didu S Kariyawasam1, Karen Herbert2

  • 1Department of Neurology, Sydney Children's Hospital Randwick, Randwick, NSW, Australia; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

Pediatric Neurology
|November 25, 2025
PubMed

Insights

Children with spinal muscular atrophy (SMA) often experience emotional and behavioral difficulties, impacting daily life. Early mental health screening and support are crucial for optimizing outcomes in these patients.

Area of Science:

  • Neurology
  • Pediatrics
  • Genetics

Background:

  • Disease-modifying therapies have altered spinal muscular atrophy (SMA) progression, highlighting the need to understand its multisystem effects.
  • Cognitive and emotional processes are increasingly recognized as affected in SMA patients.

Purpose of the Study:

  • To determine the prevalence of behavioral and emotional issues in children with symptomatic SMA.
  • To characterize the specific emotional and behavioral profiles of these children.

Main Methods:

  • A single-center, cross-sectional study involving 48 children aged 4-17 years with symptomatic SMA.
  • Emotional and behavioral problems were assessed using the Strengths and Difficulties Questionnaire (SDQ).
  • Clinical data and quality of life outcomes (Pediatric Quality of Life neuromuscular module) were collected.

Main Results:

  • 35.4% of children with SMA showed difficulties on the SDQ, significantly higher than the general population (10%).
  • 60.4% had difficulties in at least one SDQ domain, with 25% experiencing issues with hyperactivity, emotional regulation, and conduct.
  • Emotional/behavioral difficulties were perceived as a burden by 33.3% of parents and were associated with lower quality of life.

Conclusions:

  • Children with SMA exhibit significant emotional and behavioral dysregulation across all motor function levels, negatively affecting daily life.
  • These challenges persist despite varying disease severity and treatment advancements.
  • Routine mental health surveillance and psychological support are recommended for early identification and intervention to improve health outcomes.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
923
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
366
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K